| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4d43da44878829df5b78760af2718c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_000d4acc1f6bf3ba9b5c97cb98f70f69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76053dceac5d22821f9f33ef8a00392c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4dfed00095ebb32cf60406f4c9690c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7272c85c481f53ce98d573ec8409c5b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2008-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc4a3b35fcda2d1e6375fae73a92ed9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269efcaf0eb1d005cb06eb6cfde78d2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4201e25459a85ae6814a6429a3f627ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec022d1178a86d63fad3d730dc901f46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8d0747da8d1f3e9792dfc1f9581b708 |
| publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010150887-A1 |
| titleOfInvention |
Tissue Progenitor Cells That Overexpress ERG |
| abstract |
Methods for generating a population of mesodermal progenitor cells. In some aspects pluripotent cells such as stem cells are transformed with wild-type ERG expression cassette. Mesodermal progenitor cells of the invention may be used for the treatment of cardiac damage such as myocardial infarction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016185457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9574179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014037600-A1 |
| priorityDate |
2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |